Tiffany Rau PhD’s Post

Breaking News: BGF 2025 Panel Topics Revealed! ✨ Get ready for three dynamic panel discussions that tackle the biggest challenges and opportunities in biotech: 1️⃣ 2025 Cell and Gene Therapy Market 2️⃣ Conquering CGT's challenges in biomanufacturing and supply chain management 3️⃣ How new therapeutic and technology platforms are shaping the future of CGT 📅 Register now: https://bit.ly/48sG9l4 💡 Gain cutting-edge perspectives from industry leaders and experts in these can't-miss sessions! #GenScript #CellAndGeneTherapy #GenScriptBiotechGlobalForum2025 #Networking #GeneTherapy #LifeScience #Biotech #BiotechLeaders

Think ahead: preparing for challenges to accelerate your #celltherapycommercialization For successful commercialization of #CARTcelltherapies, it is critical to establish a cost-effective and reliable manufacturing process. Next month, Saba Ghassemi (Assistant Professor, Center for Cellular Immunotherapies, University of Pennsylvania), Sabrina Carmichael (Fast Trak Global Technical Leader, Cytiva), Hannah Song (Biologist, Product Development, NIH Center for Cellular Engineering), and Kathryn Henckels (Associate Director, Cell & Gene Therapy API, Johnson & Johnson) will discuss how decisions made during the early stages of process development can have long-lasting effects. Register for this #webinar below:

In today’s challenging and ever-evolving landscape of clinical trials, especially in the complex field of cell and gene therapy (CGT), the importance of focusing on the finer details cannot be overstated. Emmes AI-enabled technology allows you to go beyond traditional solutions by leveraging insights from past experiences, correcting previous errors, and accelerating the entire trial process. In a world where speed and precision are critical, it’s time to be agile, create synergies, and advance science.   We are here to offer the tools you need to make that happen. Read below to learn more. #ClinicalTrials #CellAndGeneTherapy #Biotech #ClinicalResearch #CRO #Innovation

Think ahead: preparing for challenges to accelerate your #celltherapycommercialization Later this month, Saba Ghassemi (Assistant Professor, Center for Cellular Immunotherapies, University of Pennsylvania), Sabrina Carmichael (Fast Trak Global Technical Leader, Cytiva), Hannah Song (Biologist, Product Development, NIH Center for Cellular Engineering), and Kathryn Henckels (Associate Director, Cell & Gene Therapy API, Johnson & Johnson) will discuss how decisions made during the early stages of process development can have long-lasting effects. Attend this webinar to learn about: • Establishing a cost-effective and reliable manufacturing process • The benefits of implementing the appropriate closed and automated process during early clinical trials • Critical factors necessary for the successful commercialization of an advanced therapy Register for this #webinar below:

Coeptis is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh, SNAP-CAR. Coeptis is also developing GEAR, a gene editing technology used to develop antibody resistant effector cell with VyGen-Bio, a wholly owned subsidiary of Vycellix and researchers at the Karolinska Institute. Dive into the promise of #celltherapy: https://bit.ly/3V6hoGu

Reach out to learn more about how our dedicated team here at Matica Biotechnology, Inc. can help meet your virally modified cell therapy or gene therapy preclinical production and cGMP clinical manufacturing needs! We have put together very creative options around financing strategies to support the unique needs of early stage developers (pre-clinical and early stage clinical) through these currently difficult times in the market. Just ping me to learn more! #viralvector #genetherapy #celltherapy #cGMP #ProcessDevelopment

At Eppendorf, we believe in the power of data. Now more than ever, it's crucial to test multiple cell culture growth parameters with efficiency and precision. Especially when it comes to cell and gene therapy research, being able to yield rock-solid datasets is key to keep your process-development rolling. 📈 With our software solutions, we help you control, understand, and optimize bioprocess results by enabling real-time process monitoring and rapid course corrections. But we don’t stop there – we're with you every step of the way!🚀💡 So come and talk to us, we're all ears. Let’s bioprocess together. 🙌🏼 Find out more: https://lnkd.in/ea9R7DgS #bioprocess #data #customercentricity #letsbioprocesstogether

We bring news from the cutting edge of upstream process analytics in AAV manufacturing, featuring #MassPhotometry, of course!🔬✨ In this online event, Rentschler Biopharma’s Nathan Sweeney and Cell and Gene Therapy Catapult’s Amna Anwar will present the latest findings from an ongoing project supported by InnovateUK.📊🔍 Tune in to learn about an innovative purification method coupled to mass photometry analysis that enables monitoring of empty/full AAV ratios during upstream processing with minimal time and sample consumption, addressing a significant challenge in AAV manufacturing. Register here! https://lnkd.in/g3r6KM-p

GenScript successfully hosted the European debut of our GenScript Biotech Global Forum in London, UK. Since its inaugural session at the J.P. Morgan Healthcare Conference in San Francisco in 2020, the forum has become a significant platform for advancing cell and gene therapy (CGT). This year’s move to Europe underscores GenScript’s commitment to driving the global CGT innovation and fostering international collaboration. 👏 Click to know more: https://bit.ly/4fZHX7o #cellandgenetherapy #genetherapy #JPMorgan #healthcareconference

  Landmark Bio’s Eli Kraus, Yun Chen,Ph.D., Manish Tandon and Gregg Nyberg, demonstrate application of a rapid analytical method in cutting-edge Extracellular Vesicle (EV)-based therapy biomanufacturing. Based on widely available conventional Flow Cytometer configurations, the method development was presented at the ECI Advancing Manufacture of Cell and Gene Therapies Conference in Coronado, CA. Read about the accuracy, precision, and reliable EV quantitation by Flow Cytometry, its benefit, criticality, and limitation in directly supporting clinical EV biomanufacturing platforms. #ExtracellularVesicles #FlowCytometry